Rigel Pharmaceuticals Inc

RIGL

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001034842

SEC filings (opens in a new tab)

No open-market purchases or sales by Rigel Pharmaceuticals Inc insiders were filed in the last 90 days; 155 institutions reported holding it in 13F filings for Q2 2026, worth $640.4M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Rigel Pharmaceuticals Inc changed between Q1 2022 and Q2 2022.

All holders in Q2 2022 All holders in Q1 2022

13F holders of RIGL: Q1 2022 compared with Q2 2022
Measure	Q1 2022	Of which not filed for Q2 2022	Q2 2022	Change
Holders	163	4	135	−24
Shares	135.4M	738.5K	139.2M	+4.53M (+3.4%)
Value	$405.7M	$2.21M	$157.2M	−$246.3M (−61.0%)

4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (10)

Institutions that held Rigel Pharmaceuticals Inc at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to RIGL in Q2 2022
Institution	Shares	Value	% of portfolio
Sphera Funds Management Ltd.	2,525,000	$2.85M	0.54%
Two Sigma Investments, LP	621,563	$702.0K	0.00%
UBS Oconnor LLC	431,199	$487.0K	0.01%
Caption Management, LLC	345,300	$390.0K	0.04%
Virtu Financial LLC	245,227	$277.0K	0.02%
SG Americas Securities, LLC	198,210	$224.0K	0.00%
Two Sigma Securities, LLC	36,466	$41.0K	0.01%
American Century Companies Inc	15,937	$18.0K	0.00%
Aquatic Capital Management LLC	1,200	$1.00K	0.00%
Ronald Blue Trust, Inc.	500	$1.00K	0.00%

Sold out (34)

Institutions that held Rigel Pharmaceuticals Inc at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of RIGL in Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Rock Springs Capital Management LP	4,921,487	$14.7M
Lord, Abbett & Co. LLC	4,409,833	$13.2M
Great Point Partners LLC	4,000,000	$12.0M
Laurion Capital Management LP	3,284,400	$9.82M
Walleye Capital LLC	1,049,059	$3.14M
Palo Alto Investors LP	652,395	$1.95M
ExodusPoint Capital Management, LP	418,771	$1.25M
Ameriprise Financial Inc	372,502	$1.11M
Brandywine Global Investment Management, LLC	194,400	$581.0K
HRT Financial LP	138,674	$414.0K
Ergoteles LLC	137,160	$410.0K
Qube Research & Technologies Ltd	112,005	$335.0K
Lido Advisors, LLC	69,105	$206.0K
Simplex Trading, LLC	64,116	$191.0K
DuPont Capital Management Corp	61,175	$183.0K
Engineers Gate Manager LP	34,519	$103.0K
AQR Capital Management LLC	31,105	$93.0K
Pinnacle Wealth Planning Services, Inc.	26,561	$79.0K
Marco Investment Management LLC	20,000	$60.0K
Squarepoint Ops LLC	17,644	$53.0K
Sciencast Management LP	15,681	$49.0K
Balyasny Asset Management LLC	15,487	$46.0K
Corient Capital Partners, LLC	13,262	$40.0K
Cerity Partners LLC	12,300	$37.0K
O'Shaughnessy Asset Management, LLC	10,375	$31.0K
Quadrant Capital Group LLC	6,263	$19.0K
Point72 Hong Kong Ltd	4,524	$14.0K
EverSource Wealth Advisors, LLC	3,869	$11.0K
TCI Wealth Advisors, Inc.	1,690	$5.00K
Signaturefd, LLC	353	$1.00K
Parallel Advisors, LLC	310	$1.00K
Lindbrook Capital, LLC	374	$1.00K
CWM, LLC	65	$0
TCWP LLC	212	$0

Not filed for Q2 2022 yet (4)

Institutions that held Rigel Pharmaceuticals Inc at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RIGL in Q1 2022 that haven't filed for Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
Parametric Portfolio Associates LLC	485,638	$1.45M
Virginia Retirement Systems Et Al	180,700	$540.0K
Susquehanna Fundamental Investments, LLC	44,346	$133.0K
Amalgamated Financial Corp.	27,816	$83.0K